Advertisement Barr to settle patent litigation with Ortho Women's Health & Urology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Barr to settle patent litigation with Ortho Women’s Health & Urology

Barr Pharmaceuticals has announced that the company is in discussions with Ortho Women's Health & Urology, a division of Ortho-McNeil-Janssen Pharmaceuticals, concerning a definitive agreement to settle the outstanding patent litigation involving Ortho's oral contraceptive product, Ortho Tri-Cyclen LO.

The US District Court of New Jersey has postponed the trial date. The general terms and status of the anticipated settlement will not be disclosed by either party until a definitive agreement is reached.